Sun Pharma: Traction in speciality likely to sustain Trading Calls - Equity F&O May 31, 2021Recommendations Sun Pharma’s key specialty products, particularly Ilumya (plaque psoriasis) and Cequa (dry eye disease), held up well Anubhav Sahu
